Price $1,386.51 |
Market Cap
21.67B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
25.9
|
P/B
-
|
P/S
5.73
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
26.9
|
Op. Cash Flow
969.1K
|
FCF
38.4
|
|
Op. Margin
27.60%
|
Net Margin
22.50%
|
ROE
-
|
ROI
42.80%
|
|
ROA
26.20%
|
EPS Growth
11.60%
|
Current Ratio
1.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.03 | - | - | 6.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
